- Home
- TGL vs AMIX Comparison
TGL vs AMIX Comparison
Compare TGL & AMIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TGL
- AMIX
- Stock Information
- Founded
- TGL 2020
- AMIX 2014
- Country
- TGL United States
- AMIX United States
- Employees
- TGL N/A
- AMIX N/A
- Industry
- TGL Retail: Computer Software & Peripheral Equipment
- AMIX
- Sector
- TGL Technology
- AMIX
- Exchange
- TGL Nasdaq
- AMIX NYSE
- Market Cap
- TGL 4.1M
- AMIX 3.5M
- IPO Year
- TGL 2022
- AMIX N/A
- Fundamental
- Price
- TGL $1.10
- AMIX $1.50
- Analyst Decision
- TGL
- AMIX Strong Buy
- Analyst Count
- TGL 0
- AMIX 1
- Target Price
- TGL N/A
- AMIX $5.00
- AVG Volume (30 Days)
- TGL 2.9M
- AMIX 2.6M
- Earning Date
- TGL 08-25-2025
- AMIX 08-12-2025
- Dividend Yield
- TGL N/A
- AMIX N/A
- EPS Growth
- TGL N/A
- AMIX N/A
- EPS
- TGL N/A
- AMIX N/A
- Revenue
- TGL $1,468,790.00
- AMIX N/A
- Revenue This Year
- TGL N/A
- AMIX N/A
- Revenue Next Year
- TGL N/A
- AMIX N/A
- P/E Ratio
- TGL N/A
- AMIX N/A
- Revenue Growth
- TGL N/A
- AMIX N/A
- 52 Week Low
- TGL $1.01
- AMIX $1.14
- 52 Week High
- TGL $145.00
- AMIX $42.40
- Technical
- Relative Strength Index (RSI)
- TGL 35.47
- AMIX 46.52
- Support Level
- TGL $1.22
- AMIX $1.23
- Resistance Level
- TGL $1.11
- AMIX $2.43
- Average True Range (ATR)
- TGL 0.08
- AMIX 0.18
- MACD
- TGL 0.03
- AMIX 0.04
- Stochastic Oscillator
- TGL 25.71
- AMIX 18.60
About TGL Treasure Global Inc.
Treasure Global Inc has created an online-to-offline e-commerce platform business model offering consumers and merchants instant rebates and affiliate cashback programs, while providing a seamless e-payment solution with rebates in both e-commerce and physical retailers/merchant settings. Its product is an internet application branded ZCITY app, that targets consumers by providing personalized deals based on consumers' purchase history, location and preferences.
About AMIX AUTONOMIX MEDICAL INC
Autonomix Medical Inc is a development-stage medical device development company focused on advancing technologies for sensing and treating disorders relating to the nervous system. Its first-in-class technology platform includes a catheter-based microchip-enabled array that can detect and differentiate neural signals with a high degree of sensitivity as demonstrated in animal studies.